Study to Investigate the Safety, Pharmacokinetics, and Immunogenicity of Subcutaneous MCAF5352A in Healthy Volunteers
Clinical trial NCT01480310 · COMPLETED
Trial details
- NCT number
- NCT01480310
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2012-06-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.